Overexpression of CD44 Variant 6 in Human Endometrial Cancer and Its Prognostic Significance

By Ayhan A.   Tok E.C.   Bildirici I.   Ayhan A.  

Gynecologic Oncology, Vol. 80, Iss. 3, 2001-03 ,pp. : 355-358

Elsevier

Access to resources Recommend Favorite

CD44s and CD44v6 in Diagnosis and Prognosis of Human Bladder Cancer

By Omran Ola M.   Ata Hesham S.  

Ultrastructural Pathology, Vol. 36, Iss. 3, 2012-05 ,pp. : 145-152

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Value of CD44 Splice Variants in Human Stage III Cervical Cancer

By Kainz C.   Kohlberger P.   Tempfer C.   Sliutz G.   Gitsch G.   Reinthaller A.   Breitenecker G.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1706-1709

Elsevier

Access to resources Recommend Favorite

Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis

By Lackner C.  

Breast Cancer Research and Treatment, Vol. 47, Iss. 1, 1998-01 ,pp. : 29-40

Springer Publishing Company

Access to resources Recommend Favorite

The expression of variant exon v7–v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer

By Kinoshita J.   Haga S.   Shimizu T.   Imamura H.   Watanabe O.   Kajiwara T.  

Breast Cancer Research and Treatment, Vol. 53, Iss. 2, 1999-01 ,pp. : 177-183

Springer Publishing Company

Access to resources Recommend Favorite